GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Newron Pharmaceuticals SpA (XSWX:NWRN) » Definitions » Valuation Rank

Newron Pharmaceuticals SpA (XSWX:NWRN) Valuation Rank


View and export this data going back to 2006. Start your Free Trial

What is Newron Pharmaceuticals SpA Valuation Rank?

The Valuation Rank measures the current valuation of a business relative to other companies in the same industry and its own historical valuation. The companies are split in equal numbers and then ranked from 1 to 10, with 10 as the most undervalued and 1 as the most overvalued.

  1. Three factors:
    • Absolute valuation (medpsvalue) relative to current stock price, rank among all companies
    • Historical valuation over the past 10 years. Rank pe, ps, pocf, ev2ebit over their own historical values
    • Industry relative valuation
  2. Companies without enough data is not ranked
  3. Companies with negative earnings are ranked lower

These three factors are used to calculate the value score for every eligible company, with values from 1 to 10. The final ranked companies are split in equal numbers and ranked from 1 to 10, with 10 as the most undervalued, and 1 as the most overvalued. The numbers of companies in each rank are the same.

Newron Pharmaceuticals SpA Valuation Rank Related Terms

Thank you for viewing the detailed overview of Newron Pharmaceuticals SpA's Valuation Rank provided by GuruFocus.com. Please click on the following links to see related term pages.

Newron Pharmaceuticals SpA (XSWX:NWRN) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Newron Pharmaceuticals SpA (XSWX:NWRN) » Definitions » Valuation Rank
Comparable Companies
XSWX:MOLN XSWX:SANN XSWX:XLS XSWX:RLF XSWX:ADXN XSWX:EVE XSWX:KNRS XSWX:SPEX XSWX:BSLN XSWX:IDIA OCSE:NOVO B VRTX REGN ASX:CSL XKRX:207940 MRNA XKRX:068270 XBRU:ARGX XBRU:UCB BNTX
Traded in Other Exchanges
NWPHF:USA NP5:Germany
Address
Via Antonio Meucci 3, Bresso, Milan, ITA, 20091
Website
https://www.newron.com
Newron Pharmaceuticals SpA is a biopharmaceutical company focused on the development of therapies for patients with diseases of the central and peripheral nervous system. Geographically the research and development activities are performed in Italy and the United States.
Executives
Patrick Langlois Supervisory Board